{"id":"https://openalex.org/W2114773801","doi":"https://doi.org/10.1111/j.1464-5491.2006.01942.x","title":"Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well\u2010controlled Type 2 diabetes","display_name":"Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well\u2010controlled Type 2 diabetes","alternate_titles":[],"publication_year":2006,"publication_date":"2006-09-14","ids":{"openalex":"https://openalex.org/W2114773801","doi":"https://doi.org/10.1111/j.1464-5491.2006.01942.x","mag":"2114773801","pmid":"https://pubmed.ncbi.nlm.nih.gov/16978370"},"language":"en","primary_location":{"id":"doi:10.1111/j.1464-5491.2006.01942.x","doi":"https://doi.org/10.1111/j.1464-5491.2006.01942.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-5491.2006.01942.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2114773801"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113581999","display_name":"Murray W Stewart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. W. Stewart","raw_affiliation_strings":["Solli Klinikk, Jessheim, Norway. Murray_W_Stewart@gsk.com","Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solli Klinikk, Jessheim, Norway. Murray_W_Stewart@gsk.com","institution_ids":[]},{"raw_affiliation_string":"Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050151766","display_name":"Deborah T. Cirkel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. T. Cirkel","raw_affiliation_strings":["Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110490766","display_name":"Kristian Furuseth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K. Furuseth","raw_affiliation_strings":["Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073334852","display_name":"Jill Donaldson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Donaldson","raw_affiliation_strings":["Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":null,"display_name":"N. Biswas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N. Biswas","raw_affiliation_strings":["Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044366741","display_name":"M. Starkie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. G. Starkie","raw_affiliation_strings":["Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066246012","display_name":"Costas Phenekos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Phenekos","raw_affiliation_strings":["Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108566994","display_name":"Andreas Hamann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Hamann","raw_affiliation_strings":["Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Harlow, Essex, UK, *Solli Klinikk, Jessheim, Norway, \u2020Cardiovascular and Metabolic Medicine Development Centre\u2014Clinical, GlaxoSmithKline, Greenford, Middlesex, UK, \u2021Statistics and Programming, Biomedical Data Sciences, GlaxoSmithKline, King of Prussia, PA, USA, \u00a7Korgialenio-Benakio Hospital, Athens, Greece and \u00b6Uniklinik, Innere Medical I, Heidelberg, Germany","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113581999"],"corresponding_institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":2.4881,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.88979967,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"23","issue":"10","first_page":"1069","last_page":"1078"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9229999780654907},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8479999899864197},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.921999990940094},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8420000076293945},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.8960000276565552},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.9919999837875366},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.8899999856948853},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9620000123977661},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6420000195503235},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.8429999947547913},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9670000076293945},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/drug-naive-patients","display_name":"drug-naive patients","score":0.6769999861717224},{"id":"https://openalex.org/keywords/homa-ir","display_name":"HOMA-IR","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9567849636077881},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8591717481613159},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.789556622505188},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6437123417854309},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6082755327224731},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5835185647010803},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5529221296310425},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5496741533279419},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5447756052017212},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5397518277168274},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.478253036737442},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4350040555000305},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4268772602081299},{"id":"https://openalex.org/C3018667095","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Glucose homeostasis","level":4,"score":0.4151989221572876},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.3400189280509949},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1464-5491.2006.01942.x","doi":"https://doi.org/10.1111/j.1464-5491.2006.01942.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-5491.2006.01942.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},{"id":"pmid:16978370","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16978370","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic medicine : a journal of the British Diabetic Association","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W22189248","https://openalex.org/W29271768","https://openalex.org/W201107971","https://openalex.org/W1604542334","https://openalex.org/W1663109189","https://openalex.org/W1915448748","https://openalex.org/W1968062717","https://openalex.org/W1971845216","https://openalex.org/W1972329806","https://openalex.org/W1977386411","https://openalex.org/W1979637205","https://openalex.org/W1984471891","https://openalex.org/W1993010988","https://openalex.org/W1997215980","https://openalex.org/W2011086903","https://openalex.org/W2027804378","https://openalex.org/W2036939737","https://openalex.org/W2046645679","https://openalex.org/W2063713206","https://openalex.org/W2078089300","https://openalex.org/W2082057981","https://openalex.org/W2083147531","https://openalex.org/W2094198437","https://openalex.org/W2102319947","https://openalex.org/W2114102308","https://openalex.org/W2116285515","https://openalex.org/W2116404316","https://openalex.org/W2117191092","https://openalex.org/W2123946565","https://openalex.org/W2124701241","https://openalex.org/W2131669718","https://openalex.org/W2134315188","https://openalex.org/W2154909966","https://openalex.org/W2159969745","https://openalex.org/W2160234571","https://openalex.org/W2169421904","https://openalex.org/W2188846692","https://openalex.org/W2337454357","https://openalex.org/W2419231293","https://openalex.org/W3109617681","https://openalex.org/W3198570063","https://openalex.org/W4213243604","https://openalex.org/W6608158834"],"related_works":["https://openalex.org/W2371125948","https://openalex.org/W2154909966","https://openalex.org/W2083951055","https://openalex.org/W2610262202","https://openalex.org/W3188088535","https://openalex.org/W2171519044","https://openalex.org/W2065912324","https://openalex.org/W2043610286","https://openalex.org/W2354787168","https://openalex.org/W2389559214"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"investigate":[2],"the":[3,135,166,222],"effect":[4],"of":[5,123,169,173,187,200,216,225,234,264,277,284],"metformin":[6,12],"plus":[7],"roziglitazione":[8],"(RSGMET)":[9],"compared":[10,97],"with":[11,98,109,129,165,230,239,259,271],"alone":[13],"(MET)":[14],"on":[15,29,65],"glycaemic":[16,255],"control":[17,256],"in":[18,153,185,244,262],"well-controlled":[19],"Type":[20],"2":[21],"diabetes.":[22],"METHODS:":[23],"Subjects":[24],"(drug":[25],"na\u00efve":[26],"or":[27,51,75],"those":[28],"glucose-lowering":[30],"monotherapy)":[31],"were":[32,192,227],"randomized":[33],"(n":[34],"=":[35,115,145],"526),":[36],"following":[37],"a":[38,99,171,231],"4-week":[39],"placebo":[40],"run-in":[41],"period,":[42],"to":[43,90,105,190,221,257],"RSGMET":[44,71,83,130,147,188,251],"[4":[45],"mg":[46,49],"rosiglitazone":[47],"(RSG)/500":[48],"MET]":[50],"MET":[52,76,110,191,258],"500":[53],"mg.":[54],"From":[55],"weeks":[56,63],"2-18,":[57],"medication":[58],"was":[59,138,242],"escalated":[60],"every":[61],"4":[62],"(based":[64],"gastrointestinal":[66,217],"tolerability),":[67],"then":[68],"remained":[69],"at":[70,94,126],"8":[72],"mg/2":[73],"g":[74,78],"3":[77],"for":[79,194],"14":[80],"weeks.":[81],"RESULTS:":[82],"reduced":[84],"HbA(1c)":[85,121],"from":[86,101,151],"7.2":[87,102],"+/-":[88,92,103,107],"0.6":[89,104],"6.7":[91],"0.8%":[93],"week":[95,127],"32,":[96],"reduction":[100],"6.8":[106],"0.9%":[108],"(treatment":[111],"difference":[112,137,159],"-0.13%;":[113],"P":[114,144,162],"0.0357).":[116],"More":[117],"subjects":[118,247],"achieved":[119],"an":[120],"value":[122],"</=":[124,245],"6.5%":[125],"32":[128],"(51.6":[131],"vs.":[132,237],"43.7%),":[133],"but":[134,229],"treatment":[136],"not":[139],"significant":[140,183],"(odds":[141],"ratio":[142,168],"1.37,":[143],"0.0949).":[146],"produced":[148],"larger":[149],"reductions":[150],"baseline":[152],"mean":[154],"fasting":[155],"plasma":[156],"glucose":[157],"(adjusted":[158],"-0.62":[160],"mmol/l,":[161],"<":[163,174,180],"0.0001),":[164],"odds":[167],"achieving":[170],"target":[172],"7.0":[175],"mmol/l":[176],"being":[177],"2.33":[178],"(P":[179],"0.0001).":[181],"Statistically":[182],"differences":[184],"favour":[186],"relative":[189],"seen":[193],"homeostatic":[195],"model":[196],"assessment":[197],"(HOMA)-derived":[198],"estimates":[199,263],"insulin":[201,265],"sensitivity":[202],"and":[203,210,269,274],"pancreatic":[204],"B-cell":[205,267],"function,":[206],"C-reactive":[207],"protein":[208],"(CRP),":[209],"systolic":[211],"blood":[212],"pressure.":[213],"Overall":[214],"rates":[215],"adverse":[218],"events":[219],"(relevant":[220],"known":[223],"profile":[224],"MET)":[226],"comparable,":[228],"lower":[232],"incidence":[233],"diarrhoea":[235,273],"(8":[236],"18%)":[238],"RSGMET.":[240],"Hypoglycaemia":[241],"reported":[243],"7%":[246],"per":[248],"group.":[249],"CONCLUSIONS:":[250],"provided":[252],"similar":[253],"short-term":[254],"greater":[260],"improvements":[261],"sensitivity,":[266],"function":[268],"CRP,":[270],"less":[272],"low":[275],"risk":[276],"biochemical":[278],"hypoglycaemia,":[279],"suggesting":[280],"that":[281],"early":[282],"use":[283],"combination":[285],"therapy":[286],"may":[287],"be":[288],"appropriate.":[289]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2114773801","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}
